O
SCMP

OppenheimerFunds’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

OppenheimerFunds’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-77,292
Closed -$1.39M – 1877
2017
Q4 		$1.39M Buy
77,292
+63,072
+444% +$777K ﹤0.01% 1050
2017
Q3 		$168K Sell
14,220
-5,041
-26% -$56.5K ﹤0.01% 1828
2017
Q2 		$202K Buy
19,261
+2,821
+17% +$28.8K ﹤0.01% 1821
2017
Q1 		$181K Buy
+16,440
New +$191K ﹤0.01% 1831

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

OppenheimerFunds's SCMP Position: Q1 2018 in Review

OppenheimerFunds sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 77,292 shares — an estimated $1.39M sold.

OppenheimerFunds first reported a position in SCMP in Q1 2017 and held it in 4 quarters. The position peaked at $1.39M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • OppenheimerFunds reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • OppenheimerFunds sold 77,292 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.39M.
  • OppenheimerFunds first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
  • OppenheimerFunds's Sucampo Pharmaceuticals, Inc. position peaked at $1.39M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on OppenheimerFunds's 13F filing for Q1 2018, filed 11 May 2018.